Abstract
The ever-growing success of renal transplantation in the treatment of end-stage renal disease has encouraged nephrologists and transplant surgeons to broaden its application. Previously reserved for the young, healthy individual with chronic glomerulonephritis, renal transplantation is now available to less than ideal patients, high-risk patients, and those suffering from systemic disorders. In some clinical situations such as enzyme deficiency disorders, renal transplantation may offer an advantage over dialysis in that the transplanted organ may act as a source for a deficient cell product as well as a kidney. Experience has demonstrated that transplantation can be successfully accomplished in a variety of common and uncommon renal diseases. Thus patients with many causes of renal failure have benefitted from this form of therapy. In turn, the community of practicing and investigative nephrologists has gained considerable insight into the nature of these several renal diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Fang LST: Light chain nephropathy. Kidney Int 27:582–592, 1985.
DeFronzo RA, Humphrey RL, Wright JR, Cook CR: Acute renal failure in multiple myeloma. Medicine 54:209–223, 1975.
Martinez-Maldonado M, Carayalde A: Renal involvement in multiple myeloma. In: WN Suki, G Eknoyan: The Kidney in Systemic Disease, 2nd ed. Wiley Medical, New York: pp 197–209, 1981.
Cosio FT, Pence TV, Shapiro FL, Kjellstrand CM: Severe renal failure in multiple myeloma. Clin Nephrol 15(4):206–210, 1981.
Walker F, Bear RA: Renal transplantation in light chain multiple myeloma. Am J Nephrol 3:34–37, 1983.
Gerlag PGG, Koene RAP, Berden JHM: Renal transplantation in light chain nephropathy: Case report and review of the literature. Clin Nephrol 25(2).101–104, 1986.
Spence RK, Hill GS, Goldwein MI, Grossman RA, Barker CF, Perloff LJ: Renal transplantation for end-stage myeloma kidney. Arch Surg 114:950–952, 1979.
Humphrey RL, Wright JR, Zachary JB, Sterioff S, DeFronzo RA: Renal transplantation in multiple myeloma. Ann Intern Med 83:651–653, 1975.
De Lima JJG, Kourilsky O, Meyrier A, Morel-Maroger L, Sraer JD: Kidney transplantation in multiple myeloma. Transplantation 31(3):223–224, 1981.
Medical Staff Conference: The kidney in multiple myeloma. Western J Med 129:41–59, 1978.
Briefel GR, Spees EK, Humphrey RL, Hill GS, Sarai R, Zachary JB: Renal transplantation in a patient with multiple myeloma and light chain nephropathy. Surgery 93:579–584, 1983.
Penn I: Kidney transplantation following treatment of tumors. Transplant Proc 18(4) (Suppl 3):16–20, 1986.
Bryan CW, McIntire KR, Princier GL: Effect of sustained diuresis on the renal lesions of mice with Bence-Jones protein-producing tumors. J Lab Clin Med 83(3):409–416, 1974.
Clyne DH, Pesce AJ, Thompson RE: Nephrotoxicity of Bence Jones proteins in the rat: Importance of protein isoelectric point. Kidney Int 16:345–352, 1979.
Kyle RA, Byrd ED: Amyloidosis: Review of 236 cases. Medicine 54:271–300, 1975.
Mcintosh RM, Durante D, Gilboa N: Gammopathies: Glomerular and tubular diseases. In: WN Suki, G Eknoyan, The Kidney in Systemic Disease, 2nd ed. Wiley Medical, New York: pp 140–145, 1981.
Beizer FO, Ashby BS, Gulyassy PF, Powell M: Successful seventeen-hour preservation and transplantation of human-cadaver kidney. N Engl J Med 278(11):608–610, 1968.
Kennedy CL, Castro JE: Transplantation for renal amyloidosis. Transplantation 24(5):382–385, 1977.
Dorman SA, Gamelli RL, Benziger JR, Trainer TD, Foster RS: Systemic amyloidosis involving two renal transplants. Human Patho 12(8):735–738, 1981.
Cohen AS, Bricetti AB, Harrington JT, Mannick JA: Renal transplantation in two cases of amyloidosis. Lancet 1:513–516, 1971.
Kuhlback B, Falck H, Tornroth T, Wallenius M, Lindstrom BL, Pasternack A: Renal transplantation in amyloidosis. Acta Med Scand 205:169–172, 1979.
Jones NF: Renal amyloidosis: Pathogenesis and therapy. Clin Nephrol 6(5):459–464, 1976.
Helin H, Pasternack A, Falck H, Kuhlback B: Recurrence of renal amyloid and de novo membranous glomerulonephritis after transplantation. Transplantation 32(1):6–9, 1981.
Pasternack A, Ahonen J, Kuhlback B: Renal transplantation in 45 patients with amyloidosis. 42(6):598–601, 1986.
Jacob ET, Bar-Nathan N, Shapira Z, Gafni J, Renal transplantation in the amyloidosis of familial Mediterranean fever. Arch Intern Med 139:1135–1138, 1979.
Jacob ET, Siegal B, Bar-Nathan N, Gafni J: Improving outlook for renal transplantation in amyloid nephropathy. Transplant Proc 14(1):41–45, 1982.
Wilson RE: Transplantation in patients with unusual causes of renal failure. Clin Nephrol 5(2):51–53, 1976.
Benson MD, Skinner M, Cohen AS: Amyloid deposition in a renal transplantation familial Mediterranean fever. Ann Intern Med 87:31–34, 1977.
Siegal B, Zemer D, Pras M: Cyclosporine and familial Mediterranean fever amyloidosis. Transplantation 41(6):793–794, 1986.
Skirahama T, Cohen AS: Blockage of amyloid induction by colchicine in an animal model. J Exp Med 140:1102, 1974.
Coplon NS, Diskin CJ, Petersen J, Swensen RS: The long term clinical course of systemic lupus erythematosus in end stage renal disease. N Engl J Med 308:186–190, 1983.
Cheigh JS, Stenzel KH, Rubin AL, Chami J, Sullivan JF: Systemic lupus erythematosus in patients with chronic renal failure. Am J Med 75:602–606, 1983.
Kimberly RP, Lockshin MD, Sherman RL, Beary JF, Mouradian J, Cheigh JS: “End stage” lupus nephritis: Clinical course to and outcome on dialysis. Medicine 60(4):277–287, 1981.
Roenigk HH, Haserich JR, Nakamoto S, McCormack LJ: Systemic lupus erythematosus and renal transplantation. Arch Dermatol 92:263–270, 1965.
Advisory Committee to the Renal Transplant Registry: Renal transplantation in cogenital and metabolic disease — A report from the ASC/NIH Renal Transplant Registry. JAMA 232:148–153, 1975.
Amend W, Vincenti F, Covey C, Epstein W, Feduska N, Salvatierra O: Renal transplantation in systemic lupus erythematosus. Proc Dialysis Transpl Forum 7:18–21, 1977.
Mejia G, Zimmerman SW, Glass NR, Miller DT, Sollinger HW, Beizer FO: Renal transplantation in patients with systemic lupus erythematosus. Arch Intern Med 143:2092–2098, 1983.
Buda JA, Lattes CG, Grant JP, Meltzer JI, Hsu KC, Tannenbaum M: Feasibility of renal transplantation in systemic lupus erythematosus. Surg Forum 21:252–254, 1970.
Yakub YN, Freeman RB, Pabico R: Renal transplantation in systemic lupus erythematosus. Nephron 27:197–201, 1981.
Amend WJC, Vincenti F, Feduska NJ, Salvatierra O, Johnston WH, Jackson J, Tilney N, Garovoy M, Burwell EL: Recurrent systemic lupus erythematosus involving renal allografts. Ann Intern Med 94:444–448, 1981.
Stevens J, Callendar CO, Jilly PN: Emergence of red blood cell agglutinins following renal transplantation in a patient with systemic lupus erythematosus. Transplantation 32(5):398–400, 1981.
Cats S, Terasaki PI, Perdue S, Mickey MR: Increased vulnerability of the poor donor organ in related kidney transplants for certain diseases. Transplantation 87(6):575–579, 1984.
Kimberly RP, Lockshin MD, Sherman RL, Mouradian J, Saal S: Reversible end stage lupus nephritis. Am J Med 74:361–368, 1983.
Nolph KD, Husted FC, Sharp GC, Siemsen AW: Antibodies to nuclear antigens in patients undergoing long-term hemodialysis. Am J Med 60:673–676, 1976.
Rodby RA, Korbet SM, Lewis EJ: Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis. Am J Med 83:613–618, 1987.
Steinman C, Achad A: Appearance of circulating DNA during hemodialysis. Am J Med 62:693–697, 1977.
Gladman DD, Urowitz MB, Keystone EC: Serologically active clinically quiescent systemic lupus erythematosus. Am J Med 66:210–215, 1979.
Traub YM, Shapiro AP, Rodnan GP, Medsger TA, McDonald RH, Steen VD, Osial TA, Tolchin SF: Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Medicine 62(6):335–352, 1983.
Richardson JA: Hemodialysis and kidney transplantation for renal failure from scleroderma. Arthritis Rheum 16(2):265–271, 1973.
Cannon PJ, Hassar M, Case DB: Relationship of hypertension and renal failure in scleroderma to structural and functional abnormalities of the renal cortical circulation. Medicine 53:1–45, 1974.
Keane WF, Danielson B, Raij L: Successful renal transplantation in progressive systemic sclerosis. Ann Intern Med 85:199–202, 1976.
LeRoy EC, Fleishmann RM: The management of renal scleroderma. Am J Med 84:974–978, 1978.
Oliver JA, Cannon PJ: The Kidney in scleroderma. Nephron 18:141–150, 1977.
McKinney TD, McAllister CJ, Stone WJ, Johnson HK, Ginn HE: Hemodialysis and renal transplantation in progressive systemic sclerosis: Report of two cases. Clin Nephrol 12(4):178–185, 1979.
Woodhall PB, McCoy RC, Gunnell’s JC, Seigier HF: Apparent recurrence of progressive systemic sclerosis in a renal allograft. JAMA 236(9): 1032–1034, 1976.
Merino GE, Sutherland DER, Kjellstrand CM, Simmons RL, Najarian JJ: Renal transplantation for progressive systemic sclerosis with renal failure. Am J Surg 133:745–749, 1977.
Godman GC, Churg J: Wegener’s granulomatosis: Pathology and review of the literature. Arch Pathol 58:533, 1954.
Lyons GW, Lindsay WG: Renal transplantation in a patient with Wegener’s granulomatosis. Am J Surg 124:104–107, 1972.
Kjellstrand CM, Simmons RL, Uranga VM, Buselmeier TJ, Najarian JS: Acute fulminant Wegener granulomatosis. Arch Intern Med 134:40–43, 1974.
Fauci AS, Balow JE, Brown R, Chazan J, Steinman T, Sakyoun AI, Monaco AP, Wolff SM: Successful renal transplantation in Wegener’s granulomatosis. Am J Med 60:437–440, 1976.
von Ypersele der Strihou C, Pirson Y, Vandenbroucke JM, Alexander OPJ: Hemodialysis and transplantation in Wegener’s granulomatosis. Br Med J 2:93–94, 1979.
Chandran PKG, First MR, Weiss MA, Hess EV, Alexander JW, Pazmino P, Pollak VE: Wegener’s granulomatosis: Prolonged patients survival after penumonectomy and renal transplantation. Am J Nephrol 2:325–329, 1982.
Steinman TI, Jaffe BF, Monaco AP, Wolff SM, Fauci AS: Recurrence of Wegener’s granulomatosis after kidney transplantation. Successful reinduction of remission with cyclophosphamide. Am J Med 68:458–460, 1980.
Curtis JJ, Diethelm AG, Herrera GA, Crowell WT, Whelchel JD: Recurrence of Wegener’s granulomatosis in a cadaver renal allograft. Transplantation 36(4):452–454, 1983.
Kuross S, Davis T, Kjellstrand CM: Wegener’s granulomatosis with severe renal failure: Clinical course and results of dialysis and transplantation. Clin Nephrol 16(4): 172–180, 1981.
Baliah T, Kim KH, Anthone S, Anthone R, Montes M, Andres CA: Recurrence of Henoch Schonlein purpura glomerulonephritis in transplanted kidneys. Transplantation 18(4):343–346, 1974.
Hamburger J, Crosnier J, Noel LH: Recurrent glomerulonephritis after renal transplantation. Ann Rev Med 29:67, 1978.
Weiss JH, Bhathma DB, Curtis JJ, Lucas BA, Luke RG: A possible relationship between Henoch-Schonlein syndrome and IgA nephropathy (Berger’s disease) Nephron 22:582, 1978.
Sabai T, Tanaka T, Kasai N, Shinagawa I, Endo T: Recurrence of Henoch Schonlein purpura glomerulonephritis in transplant kidneys. Sixth International Congress of Nephrology, Florence, 1975, Abstract 1023.
Levy M, Moussa RA, Habib R, Gagnadoux MF, Broyer M: Anaphylactoid purpura nephritis and transplantation. Kidney Int 22:326, 1982.
Cameron JS: Glomerulonephritis in renal transplants. Transplantation 34:237–245, 1982.
Bachman U, Biava C, Amend W, Feduska N, Melzer J, Salvatierra O, Vincenti F: The clinical course of IgA nephropathy and Henoch Schonlein purpura following renal transplantation. Transplantation 42(5):511–515, 1986.
Montalbert C, Carvallo A, Broumand B, Noble D, Anstine LA, Currier CB: Successful renal transplantation in polyarteritis nodosa. Clin Nephrol 14(4):206–209, 1980.
Wilson CB, Dixon FJ: Anti GBM antibody induced glomerulonephritis. Kidney Int 3:74–89, 1973.
Cameron JS, Turner DR: Recurrent glomerulonephritis in allografted kidneys. Clin Nephrol 7:47–54, 1977.
Cove-Smith JR, McLeod AA, Blarney RW, Knapp MS, Reeves WG, Wilson CB: Transplantation, immunosuppression and plasmapheresis in Goodpasture’s syndrome. Clin Nephrol 9(3):126–128, 1978.
Beleil OM, Coburn JW, Shinaberger JH, Glassrock RJ: Recurrent glomerulonephritis due to anti-glomerular basement membrane antibodies in two successive allografts. Clin Nephrol 1(6):377–380, 1973.
Hind CRK, Bowman C, Winearls CG, Lockwood CM: Recurrence of circulating anti-glomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange. Clin Nephrol 21(4):244–246, 1984.
Almkuist RD, Buckalew VM Jr, Hirszel P, Maher JF, James PM, Wilson CB: Recurrence of antiglomerular basement membrane antibody mediated glomerulonephritis in isog-raft. Clin Immunol Immunopathol 18:54, 1981.
Couser WG, Wallace A, Monaco AP, Lewis AP: Successful renal transplantation in patients with circulating antibody to glomerular basement membrane: Report of two cases. Clin Nephrol 1(6):381–387, 1973.
Byrnes JJ, Moake JL: Thrombotic thrombocytopenic purpura and the haemolytic uraemic syndrome: Evolving concepts of pathogenesis and therapy. Clinics Haematol 15(2):413–442, 1986.
Cerilli GJ, Nelson C, Dorfmann L: Renal homotransplantation in infants and children with the hemolytic uremic syndrome. Surgery 71(1):66–71, 1972.
Arias-Rodriguez M, Sraer JD, Kourilsky O, Smith MD, Verroust PJ, Meyrier A, Kuntziger HE, Kanfer A, Nessim V, Neuilly G, Morel-Maroger L, Richet G: Renal transplantation and immunological abnormalities in thrombotic microangiopathy of adults. Transplantation 23(4):360–365, 1977.
Folman R, Arbus GS, Churchill B, Gaum L, Huber J: Recurrence of the hemolytic uremic syndrome in a 3½ year old child, 4 months after second renal transplantation. Clin Nephrol 10(3): 121–127, 1977.
Morel Maroger L, Kanfer A, Solez K, Sraer JD, Richet G: Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic anemia (hemolytic-uremic syndrome): Clinicopathologic study in 20 adults. Kidney Int 15:548–558, 1979.
Hebert D, Sibley RK, Mauer SM: Recurrence of hemolytic uremic syndrome in renal transplant recipients. Kidney Int 30:S51–S58, 1986.
Case Records of the Massachusetts General Hospital Case 15–1986: N Engl J Med 314(16):1032–1040, 1986.
Van Den BergWolf M, Kootte AMM, Weening JJ, Paul LC: Recurrent hemolytic uremic syndrome in a renal transplant recipient and review of the Leiden experience. Transplantation 45(1):248–251, 1988.
Shulman H, Striker G, Deeg HJ, Kennedy M, Stork R, Thomas ED: Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: Glomerular thrombosis and tubular injury. N Engl J Med 305:1392–1394, 1981.
Bonser RS, Adur D, Fanklin I, McMaster P: Cyclosporin induced haemolytic-uraemic syndrome in liver allograft recipient. Lancet 2:1337, 1984.
Bergstein J, Michael A, Kellstrand C, Simmons R, Najarian J: Hemolytic-uremic syndrome in adult sisters. Transplantation 17(5):487–490, 1974.
Sun NCJ, Johnson WJ, Sung DTW, Woods JE: Idiopathic postpartum renal failure: Review and case report of a successful renal transplantation. Mayo Clin Proc 50:395–401, 1975.
Bonsib SM, Ercolani L, Ngheim D, Hamilton HE: Recurrent thrombotic microangiopathy in a renal allograft. Case report and review of the literature. Am J Med 79:520–527, 1985.
Leithner C, Sinzinger H, Pohanha E, Schwartz M, Kretschamer G, Syre G: Recurrence of hemolytic uremic syndrome triggered by cyclosporin A after renal transplantation. Lancet 2:1470, 1982.
Stevenson JA, Dumke A, Glassock RJ, Raifer J, Cohen AH: Thrombotic microangiopathy: Recurrence following renal transplant and response to plasma infusion. Am J Nephrol 2:227–231, 1982.
Robson JS, Martin AM, Puckley VA, MacDonald MK: Irreversible postpartum renal failure: A new syndrome. Q J Med 37:423–435, 1968.
Lederer ED, Truong L, Suki WN: Postpartum renal failure in a renal transplant recipient. Transplantation 47:717–719, 1989.
Skyh T-P, Beyer MM, Friedman EA: Treatment of the uremic diabetic. Nephron 40:129–138, 1985.
Tisher CC, McCoy RC: Diabetes mellitus and the kidney. In: WN Suki, G Eknoyan, eds, The Kidney in Systemic Disease, 2nd ed. Wiley Medical, New York: pp 479–507, 1981.
Maryniak RK, Mendoza, N, Clyne D, Balakrishnan K, Weiss MA: Recurrence of diabetic nodular glomerulosclerosis in a renal transplant. Transplantation 39(1):35–38, 1985.
Mauer SN, Barbosa J, Vernier RC: Development of diabetic vascular lesions in normal kidney transplanted into patients with diabetic mellitus. N Engl J Med 295:916, 1976.
Personal observation.
Abouna GM, Kremer GD, Daddah SK, Al-Adnani MS, Kumar SA, Kusma G: Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into non-diabetic recipients. Lancet 2:1274–1276, 1983.
Advisory Committee to the Renal Transplant Registry: The 13th report of the Human Renal Transplant Registry. Transplant Proc 9:9–26, 1977.
Hoitsma A, Wetzels JFM, Berden JHM, Koene RAP: Kidney transplantation in patients with diabetic nephropathy. Kidney Int 28:700, 1985.
Kjellstrand CM, Goetz FC, Shideman JR, Simmons RL, Buselmeier TJ, Von Hartitzsch B, Najarian JS: Renal transplantation in patients with insulin dependent diabetes. Lancet 2:4–8, 1973.
Totten MA, Izenstein B, Glaeson RE, Kassissieh SD, Libertino JA, D’Elia JA: Chronic renal failure in diabetes survival with hemodialysis versus transplantation. Kidney Int 12:492, 1977.
Jones RH, Rudge CJ, Watkins PJ, Bewick M, Parsons V: Renal transplantation in insulin requiring diabetics. Lancet 1:153, 1979.
Konrad P, Husberg BS, Takolander R, Bergentz SE: Renal transplantation in patients with end-stage diabetic nephropathy. Transplant Proc 14(1):28–29, 1987.
Zincke H, Woods JE, Sterioff S, Johnson WJ, Palumbo PJ, Mitchell JC, Frohnert PP, Anderson CF, Service FJ, Leary FJ: Renal transplantation in patients with diabetes mellitus-Revisited. Transplant Proc 11(1):55–59, 1979.
Jervell J, Dahl BO, Jakobsen A, Lund PK, Thayssen P, Fjeldborg O, Hansen HE, Koch B, Lindstrom B, Larson O, Brynger H, Groth CG, Lundgren G, Husberg B, Wieslander J, Frodin L, Wickstrom B: Renal transplantation in insulin treated diabetics. Transplant Proc 11(1):60–62, 1979.
Larsson O, Attman PO, Blohme I, Brynger H: Transplantation in patients with diabetic nephropathy: A 10-year experience. Transplant Proc 14(1):30–32, 1981.
Sutherland DER, Morrow CE, Fryd DS, Ferguson R, Simmons RL, Najarian HS: Improved patient and primary renal allograft survival in uremic diabetic recipients. Transplantation 34(6):319–325, 1982.
Okiye SE, Engen DE, Sterioff SS, Frohnert PP, Johnson WJ, Offord KP, Zincke H: Primary and secondary renal transplantation in diabetic patients. JAMA 249(4):492–495, 1983.
Jervell J: Joint Scandinavian report: Renal transplantation in insulin dependent diabetics. Lancet 2:915–917, 1978.
Najarian JS, Sutherland DER, Simmons RL, Howard R, Kjellstrand C, Ramsay R, Goetz F, Fryd D, Sommer B: Ten year experience with renal transplantation in juvenile onset diabetics. Ann Surg 109:487–500, 1979.
Rosenthal JT: Transplantation in diabetics with end stage renal disease transplantation and immunology. Letter 1(3): 1, 6–7, 1985.
Sutherland DER, Fryd DS, Morrow CE, et al.: Kidney transplantation in diabetics at the University of Minnesota: An analysis of results by era. Transplantation Proc 15:1110, 1983.
Sutherland DER, Fryd DS, Payne WD, Ascher N, Simmons RL, Najarian JS: Kidney transplantation in diabetics patients. Transplant Proc 19(Suppl 2):90–94, 1987.
Goldstein DA, Massry SG: Diabetic nephropathy. Clinical course and effect of hemodialysis. Nephron 20:286–296, 1978.
McCrary RF, Pitts TO, Puschett JB: Diabetics nephropathy: Natural course, survivorship and therapy. Am J Nephrol 1:206–218, 1981.
Khauli RB, Steinmuller DR, Novick AC, Buszta C, Goormastic M, Nakamoto S, Vidt DG, Magnusson M, Paganini E, Schreiber MJ: A critical look at survival of diabetics with end stage renal disease. Transplantation 41(5):598–602, 1986.
Parfrey PS, Hutchinson TA, Harvey C, Guttmann RD: Transplantation versus dialysis in diabetic patients with renal failure. Am J Kidney Dis 5(2):112–116, 1985.
Nielsen VK: The peripheral nerve function in chronic renal failure VII. Recovery after renal transplantation. Clinical aspects. Acta Med Scand 195:163, 1976.
Friedman EA, Cohen C, Lowder G, Laungani GB, Butt KMH: Cytopathy does not preclude successful kidney transplantation in diabetics. Kidney Int 29:429, 1986.
Gonzalez-Carillo M, Bewick M, Rudge C, Parsons V, Watkins P, Maloney A: Vascular complications in diabetic patients with renal transplantation. Transplant Troc 14(1);33, 1982.
Peters C, Sutherland DER, Simmons RL, Fryd DS, Najarian JS: Patient and graft survival in amputated versus nonamputated diabetic primary renal allograft recipients. Transplantation 32(6);498–503, 1981.
Rimmer JM, Sussman M, Foster R, Gennari FJ: Renal transplantation in diabetes mellitus. Influence of preexisting vascular disease on outcome. Nephron 42:304–310, 1986.
Mitchell JC: End stage renal failure in juvenile diabetes mellitus: A 5-year follow-up of treatment. Mayo Clin Troc 52:281–288, 1977.
Rao KV: The influence of pre-existing vascular disease on the outcome of renal transplantation in diabetic patients. Nephron 48:74–75, 1988.
Weinrauch LA, D’Elia JA, Healy RW, et al.: Asymptomatic coronary artery disease: Angiography in diabetic patients before renal transplantation. Ann Intern Med 88:346–348, 1978.
Braun WE, Phillips DF, Vidt DG, Novick AC, Nakamoto S, Popowniak KL, Paganini E, Magnusson M, Pohl M, Steinmuller DR, Protiva D, Buszta C: Coronary artery disease in 100 diabetics with end stage renal failure. Transplant Troc 16(3):603–607, 1984.
Feduska NJ, Vincenti F, Amend W, Iwaki I, Opel ZG, Terasaki P, Duca R, Hopper S, Salvatierra O: An alternative to cadaver kidney transplants for patients with insulin dependent diabetes mellitus. Transplantation 32(6):517–521, 1981.
Berloco P, Alfani D, Famulari A, Monari C, Trovad A, Poli L, Pritagostini R, Renna, Molajoni E, Cinti P, Marciani A, Cortesini R: Utilization of living donor organs for clinical transplantation. Transplant Troc 17(Suppl 2): 13–17, 1983.
Sabbaga E, Ianhez LE, Chocair PR, Azevedo LS, Saturi PS, de Gors GM: Kidney transplants from living nonrelated donors. An analysis of 87 cases including 20 cases with specific blood transfusions from the donor. Transplant Troc 17:1741–1745, 1985.
Reding R, Squifflet JP, Pirson Y, Jamart J, Latinni D, Alexandre GPF: Unrelated living donor kidney transplantation: Experience with 16 cases. Transplant Troc 18:1087–1089, 1986.
Bowen PA, House MA, Bairas D, Kuremsarri K, Dennis AJ, Witherington R, Humphries AL: Successful renal transplantation using distantly related or unrelated living donors with donor-specific blood transfusion. Transplantation 39:450–453, 1985.
Morrow CE, Schwartz JS, Sutherland DER, Simmons RL, Ferguson RM, Kjellstrand CM, Najarian JS: Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation. Am J Surg 146:331–335, 1983.
Philipson JD, Carpenter BJ, Itzkoff J, Hakala TR, Rosenthal JT, Taylor RJ, Puschett JB: Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med 81:630–634, 1986.
Beutler E: The sickle cell diseases and related disorders. In: WJ Williams, E Beutler, AJ Erslew, MA Lichtman, eds, Hematology, 4th ed. McGraw-Hill, New York: pp 613–644, 1990.
Vaamonde CA, Oster JR, Strauss J: The kidney in sickle cell disease. In: WN Suki, G Eknoyan, eds, The Kidney in Systemic Disease, 2nd ed. Wiley Medical, New York: pp 159–196, 1981.
Thomas AN, Pattison C, Sergeant GR: Causes of death in sickle cell disease in Jamaica. Br Med J 285:633–635, 1982.
Chatterjee SN: National study in natural history of renal allografts in sickle cell disease or trait: A second report. Transplant Troc 19(2) (Suppl 2):33–35, 1987.
Chatterjee SN, Lundberg GD, Berne TV: Sickle cell trait: Possible contributory cause of renal allograft failure. Urology 11(3):266–269, 1978.
Spector D, Zachary JB, Sterioff S, Millan J: Painful crisis following renal transplantation in sickle cell anemia. Am J Med 64:835–839, 1978.
Miner DJ, Jorkasky DK, Perloff LJ, Grossman RA, Tomaszewski JE: Recurrent sickle cell nephropathy in a transplanted kidney. Am J Kidney Dis 10(4):306–313, 1987.
Gonzalez-Carillo M, Rudge CJ, Params V, Bewick M, White JM: Renal transplantation in sickle cell disease. Clin Nephrol 18(4):209–210, 1982.
Suki WN; Polycystic kidney disease. Kidney Int 22:571–580, 1982.
Mendez R, Mendez RG, Payne JE, Berne TV: Renal transplantation in adult patients with end stage polycystic kidney disease. Urology 5(1):26–28, 1975.
Salvatierra O, Wolfson M, Cochrum K, Ammend W, Beizer FO: End stage polycystic kidney disease: Management by renal transplantation and selective use of preliminary nephrectomy. J Urol 115:5–7, 1976.
DeBono DP, Evans DB: The management of polycystic kidney diesase with special reference to dialysis and transplantation. Q J Med (New Series) 66:353–363, 1977.
SanFilippo FP, Vaughn WK, Peters TF, Bollinger RR, Spees EK: Transplantation for polycystic kidney disease. Transplantation 36(1):54–59, 1983.
Valeri A, Hardy M, Stern L, Cohen D, Appel G: Outcome of transplantation in patients with polycystic kidney disease. Kidney Int 29:437, 1986.
Williams G, Mitcheson HD, Castro JE: Transplantation for polycystic kidney disease. Urology 12(6):628–630, 1978.
Wallenius M, Kuhlback B, Brotherus JW: Renal transplantation in polycystic kidney disease. Scand J Urol Nephrol 12:75–77, 1978.
Pechan W, Novick AC, Braun WE, Nakamoto S, Popowniak K, Steinmuller D: Management of end stage polycsytic kidney disease with renal transplantation. J Urol 125:622–624, 1981.
Lytton B: Surgery of the kidney. In: PC Walsh, RF Gitter, AD Perlmutter, TA Steney, eds, Campbells Urology, 5th ed. Saunders, Philadelphia: pp 2430–2444, 1986.
Glassock RJ, Cohen AH, Adler SG, Word HJ: Secondary glomerular diseases. In: Brenner, Rector, eds, The Kidney, 3rd ed. pp 1056–1059, 1986.
McCoy RC, Johnson HK, Stone WJ, Wilson CB: Absence of nephritogenic GBM antigen(s) in some patients with hereditary nephritis. Kidney Int 21:642–652. 1982.
Brenner FP, Brynger H, Chantier C, Doncherwolche RA, Hathway RA, Jacobs C, Selwood NH, Wing AJ: Combined report on regular dialysis and transplantation in Europe. Proc Eur Dial Transpl Assoc 16:4–69, 1979.
Milliner DS, Pierdes AM, Holley KE: Renal transplantation in Alport’s syndrome. Anti-glomerular basement membrane glomerulonephritis in the allograft. Mayo Clin Proc 57:35–43, 1982.
Querin S, Noel L-H, Grunfeld J-P, Droz D, Makieu P, Berger J, Kreis H: Linear glomerular IgG fixation in renal allografts: Incidence and significance in Alport’s syndrome. Clin Nephrol 25(3): 134–140, 1986.
Mathew TH, Mathews DC, Hobbs JB, Kincaid-Smith P: Glomerular lesion after renal transplantation. Am J Med 59:1177–190, 1975.
Williams HE, Smith LH: Primary hyperoxaluria. In: Stanbury JP, Wyngaardin JB, Frederickson DS, eds, The Metabolic Basis of Inherited Disease. McGraw Hill, New York, 1972.
Yendt ER, Cohanim M: Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria. N Engl J Med 312(15):953–957, 1985.
Deodhar SD, Tung KSK, Zuhlke V, Nakamoto S: Renal homotransplantation in a patient with primary familial oxalosis. Arch Pathol 87:118–124, 1969.
Klauwers J, Wolf PL, Cohn R: Failure of renal transplantation in primary oxalosis. JAMA 209:551, 1969.
Saxon A, Busch GJ, Merrill JP: Franco V, Wilson RE: Renal transplantation in primary hyperoxaluria. Arch Intern Med 133:464–467, 1974.
Koch B, Irvine AH, Barr JR, Poxnanski WJ: Thru kidney transplantation in a patient with primary hereditary hyperoxaluria. Can Med Assoc J 106:1323–1331, 1972.
Morgan JM, Hartley MW, Miller AC, Diethelm AG: Successful renal transplantation in the hyperoxaluria. Arch Surg 109:430–433, 1974.
Toussaint C, Goffin Y, Potuliege P, Dupuis F, Dupont E, Toussaint D, Kinnaert P, van Gurtruyden J, Vereerstraeten P: Kidney transplantation in primary oxalosis. Clin Nephrol 5(5):239–244, 1976.
Leuman EP, Wegman W, Largiarder F: Prolonged survival after renal transplantation in primary hyperoxaluria of childhood. Clin Nephrol 9(1):29–34, 1978.
Scheinman JI, Najarian JS, Mauer SM: Successful strategies for renal transplantation in primary oxalosis. Kidney Int 25:804–811, 1984.
Haiverstadt DB, Wenzl JE: Primary hyperoxaluria and renal transplantation. J Urol 111:398–402, 1974.
O’Regan P, Constable AR, Koekes AM, Kasidas GP, Rose GA: Successful renal transplantation in primary hyperoxaluria. Postgrad Med J 56:288–293, 1980.
Bohannon LL, Norman DJ, Barry J, Bennett WM: Cadaveric renal transplantation in a patient with primary hyperoxaluria. Transplantation 36(1):114–115, 1983.
David DS, Cheigh JS, Stenzel KH, Rubin AL: Successful renal transplantation in a patient with primary hyperoxaluria. Transplant Proc 15(4):2168–2171, 1983.
Whelchel JD, Alison DV, Luke RG, Curtis J, Diethelm AG: Successful renal transplantation in hyperoxaluria. Transplantation 35(2):161–164, 1983.
Adams ND, Carrera GF, Johnson RP, Latorracci R, Lemann J: Calcium-oxalate-crystal-induced bone disease. Am J Kidney Dis 1(5):294–299, 1982.
Blackburn WE, McRoberts JW, Bhathena D, Vazquez M, Luke RG, Severe vascular complications in oxalosis after bilateral nephrectomy. Ann Intern Med 82:44–46, 1975.
Veerenterghem Y, Vandamme B, Lerut T, Michielson P: Severe vascular complications in oxalosis after successful cadaveric kidney transplantation. Transplantation 38:93–95, 1984.
Watts RWE, Calne RY, Williams R, Mansell MA, Veall N, Purkiss P, Rolles K: Primary hyperoxaluria (type I): Attempted treatment by combined hepatic and renal transplantation. Q J Med 57:697–702, 1985.
Watts RWA, Rolles K, Morgan SH, William R, Calne RY, Danpure CJ, Mansell MA, Purkiss P: Successful treatment of primary hyperoxaluria type I by combined hepatic and renal transplantation. Lancet 2:474–485, 1987.
Schneider JA, Schulman JD: Cystinosis. In: JB Stanbury, JB Wyngaarden, DS Fredrickson, JL Goldstein, MS Brown, eds, The Metabolic Basis of Inherited Disease. McGraw-Hill, New York, pp 1844–1866, 1983.
Broyer M, Donderwolcke RA, Brunner FP, Brynger H, Jacobs C, Kramer P, Selwood NH, Wing AJ, Blake PH: Combined report on regular dialysis and transplantation of children in Europe, 1980. Proc Eur Dial Transpl Assoc 18:60–87, 1981.
Langlois RP, O’Regan S, Pelleteier M, Robitaille P: Kidney transplantation in uremic children with cystinosis. Nephron 28:273–275, 1981.
Gahl WA, Schneider JA, Thoene JG, Chesney R: Course of nephropathic cystinosis after age 10 years. J Pediatr 109:605–608, 1986.
Lawson RK, Talwalkar YB, Hodges CV: Renal transplantation in cystonosis. J Urol 113:552–555, 1975.
Malekzadeh MH, Pennisi AJ, Phillips L, Ettenger RD, Uittenbogaart CH, Fine RN: Growth and endocrine function in children with cystonosis following renal transplantation. Trans Am Soc Artif Intern Org 24:278–281, 1978.
West JC, Goodman SI, Seproter GP, Bloustein PA, Hambridge KM, Weil R: Pediatric kidney transplantation for cystonosis. J Pediatr Surg 12(5):651–655, 1977.
Malekzadeh MH, Neustein HB, Schneider JA, Pennisi AJ, Ettenger RB, Uittenbogaart CH, Kogut MD, Fine RN: Cadaver renal transplantation in children with cystinosis. Am J Med 63:525–533, 1977.
Mahoney CP, Striker GE, Hickman RO, Manning GB, Marchioro TL: Renal transplantation for childhood cystinosis. N Engl Med 283(8):397–402, 1970.
Mahoney CP, Striker GE, Fetherman GH, Hickman RO, Schneider JA, Marchioro TL: Renal transplantation in childhood cystinosis. Effects of the metabolic disease and renal allografts on each other. Birth defects. Original article series 9(2):140–141, 1973.
Broyer M, Gagnadoux UF, Bearton D, Parcal B, Lowifle J: Transplantation in children: Technical aspects, drug therapy and problems related to primary renal disease. Proc Eur Dial Transpl Assoc 18:313–321, 1981.
Desnick RJ, Sweeley CC: Fabry’s disease: Galactosidase deficiency. In: JB Stanbury, JB Wyngaarden, DS Fredickson, JL Goldstein, MS Brown, eds. The Metabolic Basis of Inherited Disease, 5th ed. McGraw Hill, New York, pp 906–944, 1983.
Philippart M, Franklin SS, Gordon A: Reversal of an inborn sphingolipidosis (Fabry’s disease) by kidney transplantation. Ann Intern Med 77:195–200, 1972.
Philippart M: Fabry disease: Kidney Transplantation on an enzyme replacement therapy, Birth Defects 9(2):81–87, 1973.
Desnick RJ, Allen KY, Simmons RL, Woods JE, Anderson CF, Najarian JS, Krivit W: Fabry disease: Correction of the enzymatic deficiency by renal transplantation. Birth Defects. 9(2):88–96, 1973.
Venden Bergh FAJTM, Rietra PJGM, Kolh-Vegter AJ, Bosch E, Tager JM: Therapeutic implications of renal trans-plantation in a patient with Fabry’s disease. Acta Med Scand 200:249–256, 1976.
Maizel SE, Simmons RL, Kjellstrand C, Fryd DS: Ten year experience in renal transplantation for Fabry’s disease. Transplant Proc 13(1):57–59, 1981.
Donati D, Novari OR, Gastaedi L: Natural history and treatment of uremia secondary to Fabry’s disease: An European experience. Nephron 46:353–359, 1987.
Kramer W, Thorman J, Mueller K, Frenzel H: Progressive cardiac involvement by Fabry’s disease despite successful renal allo-transplantation. Int J Cardiol 7:72–75, 1985.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Kluwer Academic Publishers
About this chapter
Cite this chapter
Lederer, E.D., Suki, W.N. (1991). Renal Transplantation in Systemic Inherited and Metabolic Disease. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0689-4_59
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0689-4_59
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8027-9
Online ISBN: 978-1-4613-0689-4
eBook Packages: Springer Book Archive